Rennwik Innovation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -107.58%
- Ebitda -101.37%
- Net Worth -6.78%
- Total Assets -8.36%
About Rennwik Innovation
Rennwik Innovation Private Limited (RIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 April 2018 (Six years and nine months 22 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vetri Aegan and Jambu Deepak serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TN2018PTC122221
-
Company No.
122221
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 2018
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Rennwik Innovation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vetri Aegan
|
Director | 01-Apr-2021 | Current |
|
Jambu Deepak
|
Director | 01-Apr-2021 | Current |
Financial Performance of Rennwik Innovation.
Rennwik Innovation Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 107.58% decrease in profit. The company's net worth dipped by a decrease of 6.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rennwik Innovation?
Unlock access to Rennwik Innovation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hexacara Life Sciences Private LimitedVetri Aegan and Jambu Deepak are mutual person
-
Hexacara Holdings Private Limited
Vetri Aegan and Jambu Deepak are mutual person
-
Hexacara Hospitals Private Limited
Vetri Aegan and Jambu Deepak are mutual person
-
Iris Med Labs Private Limited
Jambu Deepak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rennwik Innovation?
Unlock and access historical data on people associated with Rennwik Innovation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rennwik Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rennwik Innovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
